GlassScriptPhysician profile
Suzanne Forman Strand
NPI 1457748576
$2,638.23
in general payments reported to CMS, 2019-2025
14 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $926 · 2020: $501 · 2022: $408 · 2023: $476 · 2024: $176 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $802.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $802.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $616.17 | 2019-2023 | Relieva Spinplus |
| Intersect Ent, INC. | $495.18 | 2019-2020 | |
| Inspire Medical Systems, INC. | $344.54 | 2022-2025 | Inspire |
| Medtronic, INC. | $279.47 | 2023-2025 | Propel, Nuvent, Pteye Parathyroid Detection System |
| Medtronic USA, INC. | $208.03 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $207.46 | 2022-2024 | Dupixent |
| Smith+Nephew, INC. | $175.60 | 2020 | |
| Aerin Medical INC. | $143.40 | 2019-2023 | |
| Alk-Abello, INC | $40.85 | 2019-2025 | Grastek, Ragwitek, Odactra |
| Integra Lifesciences Corporation | $38.47 | 2022 | |
| Merck Sharp & Dohme LLC | $29.74 | 2023 | |
| Kaleo, INC. | $26.42 | 2022 | |
| Karl Storz Endoscopy-America | $19.31 | 2024 | |
| Genzyme Corporation | $13.59 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suzanne Strand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.